Gradient Investments’s CNS Pharmaceuticals CNSP Stock Holding History

Gradient Investments’s Portfolio CNSP Stock Details CNSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	-$7	–	1785
2023 Q1	–	Hold	0	–	–	–	1492
2022 Q4	–	Hold	0	–	–	–	1479
2022 Q3	–	Hold	0	–	–	–	1367
2022 Q2	–	Hold	0	–	–	–	1237
2022 Q1	–	Hold	0	–	–	–	1199
2021 Q4	–	Hold	0	–	–	–	1240
2021 Q3	–	Hold	0	–	–	–	1152
2021 Q2	–	Hold	0	–	–	–	1161
2021 Q1	–	Hold	0	–	–	–	1169
2020 Q4	–	Hold	0	–	–	–	1138
2020 Q3	–	Hold	0	–	–	–	1151
2020 Q2	–	Hold	0	–	–	–	1065
2020 Q1	–	Hold	0	–	–	–	1110
2019 Q4	–	Hold	0	–	–	–	996

Other funds holding CNSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FSM Wealth Advisors Cleveland, Ohio $939M AUM 22.84% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Global Retirement Partners San Rafael, California $5.64B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return